Strategic Blueprint’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Strategic Blueprint's AMGN Position: Q3 2026 in Review
Strategic Blueprint increased its Amgen (AMGN) stake by 104% in Q3 2026, buying an estimated $612K and bringing the position to 3,013 shares worth $1.27M. The position accounts for 0.06% of the portfolio, ranked #265.
Strategic Blueprint first reported a position in AMGN in Q3 2019 and has held it in 21 quarters since. The position peaked at $2.45M in Q3 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Strategic Blueprint held 3,013 shares of Amgen worth $1.27M as of Q3 2026.
- Strategic Blueprint bought 1,536 Amgen shares in Q3 2026, an estimated $612K.
- Amgen made up 0.06% of Strategic Blueprint's portfolio in Q3 2026, its #265 holding.
- Strategic Blueprint first reported a position in Amgen in Q3 2019 and has held it in 21 quarters since.
- Strategic Blueprint's Amgen position peaked at $2.45M in Q3 2025.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Strategic Blueprint's 13F filing for Q3 2026, filed 22 Oct 2026.